LLY

Eli Lilly News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Eli Lilly and Co LLY NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.78 0.4% 195.72 20:00:00
Open Price Low Price High Price Close Price Prev Close
194.94 194.92 197.27 196.21 194.94
more quote information »

Recent News

Date Time Source Heading
5/13/202110:00PRNUSLilly to Participate in UBS Global Healthcare Virtual..
5/11/202113:50SEEKDr Reddy's strikes licensing deal with Lilly for Baricitinib
5/11/202108:07DJNEli Lilly, MiNA Therapeutics Join in Research Collaboration
5/11/202107:02SEEKLilly, MiNA Therapeutics ink saRNA research collaboration
5/11/202106:45PRNUSLilly and MiNA Therapeutics Announce saRNA Research..
5/10/202116:34EDGARInitial Statement of Beneficial Ownership (3)
5/06/202106:45PRNUSLilly collaborates internationally with leading diabetes..
5/05/202113:22SEEKLilly implicated in production lapses at two of its plants
5/05/202110:00PRNUSLilly to Participate in Bank of America Securities 2021..
5/05/202107:37EDGARSpecialized Disclosure Report (sd)
5/05/202106:58EDGARCurrent Report Filing (8-k)
5/04/202111:40SEEKShares of major drug makers in focus as House committees..
5/04/202110:19SEEKLilly-AbCellera collaboration develops new antibody that can..
5/04/202110:07PRNUSLilly plans donation of COVID-19 therapies to Direct Relief..
5/04/202108:32DJNEli Lilly Accelerates Baricitinib Availability in India Amid..
5/04/202107:00PRNUSLilly Outlines Robust Plans to Strengthen ESG Commitments..
5/04/202106:42PRNUSLilly accelerating baricitinib's availability in India..
5/03/202119:02EDGARStatement of Changes in Beneficial Ownership (4)
5/03/202117:04SEEKEli Lilly declares $0.85 dividend
5/03/202116:31SEEKEli Lilly adds $5 billion to buyback authorization
5/03/202115:28PRNUSLilly Declares Second-Quarter 2021 Dividend and Announces..
5/03/202110:00PRNUSLilly to Commit $5 Million to Direct Relief's Fund for..
4/30/202109:24EDGARQuarterly Report (10-q)
4/27/202107:30DJNEli Lilly Tightens Full-Year Guidance Ranges
4/27/202107:21DJNEli Lilly 1Q Revenue Grows, but Profit Falls on Higher Costs
4/27/202107:17SEEKLilly slips 4% as Q4 trails estimates; Guidance lags..
4/27/202106:49EDGARCurrent Report Filing (8-k)
4/27/202106:26SEEKEli Lilly EPS misses by $0.23, misses on revenue
4/27/202106:25PRNUSLilly Delivers First-Quarter 2021 Financial Results, Adjusts..
4/26/202112:36SEEKEli Lilly Q1 2021 Earnings Preview
4/23/202111:52SEEKIncyte presents more data from positive late-stage studies..
4/23/202110:01PRNUSOLUMIANT® Showed Significant Improvements in the Severity..
4/21/202116:28EDGARStatement of Changes in Beneficial Ownership (4)
4/21/202116:24EDGARStatement of Changes in Beneficial Ownership (4)
4/20/202107:47DJNEli Lilly, Incyte: Baricitinib Improves Hair Regrowth in..
4/20/202106:45PRNUSLilly and Incyte's Baricitinib Improved Hair Regrowth for..
4/19/202107:13TRMNEli Lilly And Incyte’s Baricitinib Fails To Meet Endpoint In..
4/16/202118:09DJNLilly Ends U.S. Use of Single Covid-19 Antibody Drug Alone..
4/16/202106:59DJNNew Covid-19 Strains Prompt Lilly to Seek to End U.S. Use of..
4/16/202106:30PRNUSLilly requests revocation of emergency use authorization for..
4/14/202107:35SEEKEli Lilly and SciNeuro Pharmaceuticals ink exclusive license..
4/13/202107:08DJNEli Lilly Names Diogo Rau Chief Information, Digital Officer
4/13/202106:30PRNUSDiogo Rau to join Lilly as Senior Vice-President and Chief..
4/12/202107:27DJNEli Lilly Changes U.S. Supply Agreement for Covid-19 Drugs
4/12/202107:21SEEKEli Lilly and U.S. government amend supply agreement for..
4/12/202106:45PRNUSLilly modified COVID-19 purchase agreement for bamlanivimab..
4/12/202105:06SEEKLilly's retevmo shows antitumor activity in solid tumors
4/11/202114:00PRNUSLilly Presents New Data on Retevmo® (selpercatinib) in..
4/08/202107:44DJNLilly, Incyte Phase 3 Study of Covid-19 Drug Didn't Meet..
4/08/202106:45PRNUSLilly and Incyte announce results from the Phase 3..
See more news about this stock »


Your Recent History
NYSE
LLY
Eli Lilly
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.